Abstract
No public abstract is available from the verified source records.
Open public full textRights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Monika M. Toma, Adam Karami, Margaret Nieborowska-Skorska, Tomasz Skorski
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Multi-omic profiling of the leukemic microenvironment shows bone marrow interstitial fluid is distinct from peripheral blood plasma
10.1186/s40164-022-00310-0 · 2022
Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression
10.21037/atm-23-1824 · 2024
Emerging bone marrow microenvironment-driven mechanisms of drug resistance in acute myeloid leukemia: tangle or chance?
10.3390/cancers13215319 · 2021
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
10.1038/s41467-020-19119-8 · 2020
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
10.1038/nm.4210 · 2016
Loss of KDM6A confers drug resistance in acute myeloid leukemia
10.1038/s41375-019-0497-6 · 2020
TP53 mutations in acute leukemias and myelodysplastic syndromes: insights and treatment updates
10.1200/edbk_432650 · 2024
Similarities and differences of bone marrow and peripheral blood samples from acute myeloid leukemia patients in terms of cellular heterogeneity and ex-vivo drug sensitivity
10.1002/jha2.961 · 2024
Functional heterogeneity of genetically defined subclones in acute myeloid leukemia
10.1016/j.ccr.2014.01.031 · 2014
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones
10.1182/bloodadvances.2022008521 · 2023
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
10.1182/bloodadvances.2020001582 · 2020
Clonal medicine targeting DNA damage response eradicates leukemia
10.1038/s41375-024-02138-5 · 2024
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
10.1056/nejmoa1112304 · 2012
Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution
10.1186/s40164-022-00319-5 · 2022
No additional external references are available.